Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 276 participants.
Also called NCT04405258
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 276 participants
- Sponsor
- Institute for Clinical Effectiveness, Japan
- Registry
-
NCT04405258
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Unknown status
Technical summary
Registry record NCT04405258. Randomized; single masking; primary purpose treatment. Start 2020-06-08 (actual); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial
- Acronym
- LEAP-AF
- Condition
- Persistent Atrial Fibrillation
- Condition
- Catheter Ablation
- Condition
- Pulmonary Vein Isolation
- Condition
- Posterior Wall Isolation
- Intervention (Procedure)
- Pulmonary vein isolation
- Intervention (Procedure)
- Left posterior wall isolation
- Lead sponsor
- Institute for Clinical Effectiveness, Japan
Record details
- Record id
cardio:ct-nct04405258- Content hash
b334017c4c9ebb4393a4b54d219efcadbdc363dcc9f4cb4385dfd79a92b1db9a